ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2405

Musculoskeletal Manifestations As Presenting Symptoms of Inflammatory Bowel Disease in Children and Adolescents

Rachel Levy1, Gil Amarilyo2,3, Jacob Amir4, Rotem Tal2,3, Amit Assa3,5, Firas Rinawi5 and Liora Harel2,3, 1The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel, 2Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel, 3Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, Tel Aviv, Israel, 4Mayanei Hayeshua Medical Center, Bnei Brak, Israel, 5Institute of Gastroenterology Hepatology and Liver diseases, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Arthritis, inflammatory bowel disease (IBD), pediatric rheumatology and pediatrics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster III: Systemic JIA, Autoinflammatory Syndromes, Scleroderma, Vasculitis, Miscellaneous

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Extra intestinal manifestations occur in 40-50% of patients with inflammatory bowel disease (IBD), with musculoskeletal involvement in 25%. Data regarding musculoskeletal manifestations in the pediatric population are scarce. The purpose of this study was to compare pediatric IBD patients initially presenting with arthritis, to patients presenting with arthritis of other etiologies, in order to identify clinical and laboratory red flags that may arouse suspicion of IBD.

Methods:  This retrospective cohort study included patients followed up at “Schneider Children’s Medical Center of Israel” between 1985-2016. We identified 23 children with IBD who presented with arthritis and matched them to a control group of 46 children. The latter included 21 patients with Juvenile Idiopathic Arthritis, 7 patients with Familial Mediterranean Fever and 18 patients with postinfectious arthritis. Clinical and laboratory data were collected and compared between the two groups. Fisher’s exact test, χ 2and analysis of variance were used for statistical processing.

Results:  The most statistically significant clinical factor at presentation which predicted IBD was sacroiliitis (30.4% in IBD group vs. 2.2% in control group, P<0.001), and was more common in females (46.15% vs. 20% respectively). Additive arthritis was exclusive to the IBD group (21.7%). Twenty five percent of the IBD group reported a positive family history for IBD (mostly Crohn’s Disease).The IBD group showed decreased hemoglobin and MCV levels as well as elevated RDW as compared to control (10.5, 69.1, 14.9 vs 12.0, 79.1, 13.2 respectively, P<0.001). Albumin mean values were lower in the IBD group compared to control (3.5 vs. 4.3 respectively, P<0.001). Upon direct questioning of the IBD group at presentation, the following abdominal symptoms were reported: diarrhea (43.5%), abdominal pain (39.1%), weight loss (34.8%), fever (21.7%), aphthous ulcers (17.4%), bloody stools (13%) and vomiting (8.7%). Despite these signs and symptoms 8.7% of children were diagnosed with IBD at presentation, whilst 26% were diagnosed at a delay of >1 year. The overall mean time from arthritis presentation to IBD diagnosis was 1.17±1.89 years. Three patients (13.04%) from the IBD group developed residual joint damage.

Conclusion:   Arthritis, specifically sacroiliitis, associated with microcytic anemia and/or hypoalbuminemia in children without specific signs of IBD should be considered red flags, and arouse suspicion for this disease, thus mandating thorough enquiry.


Disclosure: R. Levy, None; G. Amarilyo, None; J. Amir, None; R. Tal, None; A. Assa, None; F. Rinawi, None; L. Harel, None.

To cite this abstract in AMA style:

Levy R, Amarilyo G, Amir J, Tal R, Assa A, Rinawi F, Harel L. Musculoskeletal Manifestations As Presenting Symptoms of Inflammatory Bowel Disease in Children and Adolescents [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/musculoskeletal-manifestations-as-presenting-symptoms-of-inflammatory-bowel-disease-in-children-and-adolescents/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/musculoskeletal-manifestations-as-presenting-symptoms-of-inflammatory-bowel-disease-in-children-and-adolescents/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology